EXHIBIT 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Idera Pharmaceuticals, Inc. 2022 Stock Incentive Plan and the Aceragen, Inc. 2021 Stock Incentive Plan of our report dated March 31, 2022, with respect to the financial statements of Idera Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.

Philadelphia, Pennsylvania

February 1, 2023